| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.095 | 0.05 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | -0.084 | 0.07 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | 0.077 | 0.1 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | -0.07 | 0.1 |
| mRNA | Topotecan | CCLE | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | Nutlin-3 | CCLE | pan-cancer | AAC | 0.069 | 0.1 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.071 | 0.2 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.046 | 0.3 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | -0.042 | 0.3 |